Raras
Buscar doenças, sintomas, genes...
Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia
ORPHA:2798CID-10 · G40.4OMIM 600176PCDT · SUSDOENÇA RARA

É uma doença neurológica genética rara, caracterizada pela presença de dobras cerebrais mais grossas e em menor número (conhecido como paquigiria difusa) e cistos aracnoides (bolsas de líquido que se formam no cérebro). Também causa atraso no desenvolvimento (que afeta os movimentos e a capacidade de aprender) e deficiência intelectual. Convulsões (crises epilépticas), de tipos variados — como as de ausência (momentos em que a pessoa parece "desligar" por alguns segundos), as atônicas (perda súbita de força muscular) e as tônico-clônicas generalizadas (com tremores e rigidez do corpo) — e, ocasionalmente, dores de cabeça também podem ocorrer.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença neurológica genética rara, caracterizada pela presença de dobras cerebrais mais grossas e em menor número (conhecido como paquigiria difusa) e cistos aracnoides (bolsas de líquido que se formam no cérebro). Também causa atraso no desenvolvimento (que afeta os movimentos e a capacidade de aprender) e deficiência intelectual. Convulsões (crises epilépticas), de tipos variados — como as de ausência (momentos em que a pessoa parece "desligar" por alguns segundos), as atônicas (perda súbita de força muscular) e as tônico-clônicas generalizadas (com tremores e rigidez do corpo) — e, ocasionalmente, dores de cabeça também podem ocorrer.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
5
pacientes catalogados
Início
Childhood
🏥
SUS: Cobertura parcialScore: 65%
PCDT disponívelCentros em: PA, PE, CE, DF, SP +5CID-10: G40.4
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
7 sintomas
🦴
Ossos e articulações
2 sintomas

+ 3 sintomas em outras categorias

Características mais comuns

90%prev.
Deficiência intelectual, grave
Muito frequente (99-80%)
90%prev.
Atraso global do desenvolvimento
Muito frequente (99-80%)
90%prev.
Convulsão
Muito frequente (99-80%)
55%prev.
Nascimento prematuro
Frequente (79-30%)
Paquigiria
Cisto aracnoide
12sintomas
Muito frequente (3)
Frequente (1)
Sem dados (8)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 12 características clínicas mais associadas, ordenadas por frequência.

Deficiência intelectual, graveIntellectual disability, severe
Muito frequente (99-80%)90%
Atraso global do desenvolvimentoGlobal developmental delay
Muito frequente (99-80%)90%
ConvulsãoSeizure
Muito frequente (99-80%)90%
Nascimento prematuroPremature birth
Frequente (79-30%)55%
PaquigiriaPachygyria

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos133publicações
Pico202522 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia

Centros para Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies.

Annals of clinical and translational neurology2026 Jan

Parkinson's disease (PD) is a neurodegenerative disorder that may sometimes be caused by deleterious genetic variants. Among them, RAB39B polymorphisms are known as rare causes of early-onset PD associated with intellectual disability (Waisman's syndrome). Here we describe a 45-year-old white male affected by developmental delay, childhood onset intellectual disability, epilepsy, and PD who was treated with subthalamic deep brain stimulation and subcutaneous L-DOPA infusion. Next Generation Sequencing analysis revealed a currently unknown pathogenic hemizygous sequence variant c.463C>T (NM_171998.4) in the RAB39B gene, confirmed also in the proband's mother, affected by late-onset PD. This report expands the number of described RAB39B mutations in individuals with early- and late-onset, X-linked PD. The clinical manifestations of CACNA1C-related disorders include a spectrum of nonsyndromic and syndromic phenotypes, which generally correlate with the impact of the pathogenic variant on calcium current. Phenotypes can include nonsyndromic long QT syndrome (rate-corrected QT [QTc] interval >480 ms); nonsyndromic short QT syndrome (QTc <350 ms), with risk of sudden death; Brugada syndrome (ST segment elevation in right precordial leads [V1-V2]) with short QT interval; classic Timothy syndrome (prolonged QT interval, autism, and congenital heart defect) with or without unilateral or bilateral cutaneous syndactyly variably involving fingers two (index), three (middle), four (ring), and five (little) and bilateral cutaneous syndactyly of toes two and three; and CACNA1C-related neurodevelopmental disorder, in which the features tend to favor one or more of the following: developmental delay / intellectual disability, hypotonia, epilepsy, and/or ataxia. The diagnosis of a CACNA1C-related disorder is established in a proband with suggestive findings and a heterozygous pathogenic variant in CACNA1C identified by molecular genetic testing. Treatment of manifestations: Beta-blockers (nadolol preferred) and mexiletine may be used for prolonged QT interval; pacemaker placement / temporary pacing for bradycardia with 2:1 atrioventricular block; quinidine for short QT syndrome and Brugada syndrome; consideration of catheter ablation for symptomatic Brugada syndrome; implantable cardioverter defibrillator (ICD) as soon as body weight allows for those with tachyarrhythmias; feeding therapy with low threshold for clinical feeding evaluation and/or radiographic swallowing study for dysphagia; consideration of gastrostomy tube placement for persistent feeding issues; standard treatment for congenital heart defects, developmental delay / intellectual disability, epilepsy, ataxia, hypoglycemia, recurrent infections, and syndactyly. Prevention of primary manifestations: Arrhythmias must be prevented with the standard therapy, which may include medications, placement of an ICD, and/or ablation. Any surgical intervention must be performed under close cardiac monitoring, as anesthesia is a known trigger for cardiac arrhythmia in individuals with a CACNA1C-related disorder; fever can also be a trigger for arrhythmias in individuals with CACNA1C-related Brugada syndrome and requires aggressive treatment with standard antipyretic drugs. Surveillance: At each visit, measure growth parameters and evaluate nutritional safety of oral intake; assess mobility and self-help skills; monitor developmental progress and educational needs; assess for behavioral issues; assess for new manifestations such as seizures, changes in tone, and movement disorders; monitor for signs/symptoms of hypoglycemia; and monitor for recurrent infections. Every 6-12 months, follow-up evaluations with a cardiologist to include EKG, Holter, & echocardiogram; monitor those with seizures as clinically indicated. Every 12 months, if remote device monitoring is available: evaluate persons with a pacemaker or ICD. Agents/circumstances to avoid: All drugs reported to prolong QT interval (see CredibleMeds®); drugs and dietary practices that could lead to hypoglycemia. Evaluation of relatives at risk: It is appropriate to clarify the genetic status of the older and younger at-risk relatives of a proband in order to identify as early as possible those who would benefit from a complete cardiac evaluation, institution of measures to prevent cardiac arrhythmias, and awareness of agents/circumstances to avoid. Predictive genetic testing is recommended for all at-risk family members of all ages from birth onward. While predictive genetic testing can be used to identify relatives who are heterozygous for a familial CACNA1C pathogenic variant and at risk for CACNA1C-related cardiac arrhythmias, it cannot be used to predict disease course (i.e., whether CACNA1C-related EKG changes and symptoms will occur and, if so, the age of onset and severity). Pregnancy management: Nadolol (the beta-blocker of choice for individuals with long QT syndrome in general) has not been associated with an increased risk above the general population risk of congenital anomalies in humans. Quinidine for short QT syndrome is also a preferred drug for use as an antiarrhythmic during human pregnancy and has not been associated with adverse fetal effects. Fetuses at risk of being affected with a CACNA1C-related disorder should be monitored for bradycardia and heart rate abnormalities that can be a sign of fetal arrhythmias. CACNA1C-related disorders are inherited in an autosomal dominant manner. Many individuals diagnosed with a CACNA1C-related disorder – particularly those individuals with a syndromic CACNA1C-related disorder (Timothy syndrome or CACNA1C-related neurodevelopmental syndrome) – have the disorder as the result of a de novo pathogenic variant. Some individuals diagnosed with a CACNA1C-related disorder inherited the CACNA1C pathogenic variant from a heterozygous or mosaic parent. If a parent of the proband is affected and/or is known to be heterozygous for the pathogenic variant identified in the proband, the risk to the sibs of inheriting the pathogenic variant is 50%. If the proband has a known CACNA1C pathogenic variant that cannot be detected in the leukocyte DNA of either parent, the recurrence risk to sibs is greater than that of the general population because of the possibility of parental gonadal mosaicism. Once the CACNA1C pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing for a pregnancy at increased risk for a CACNA1C-related disorder are possible.

#2

Lamb-Shaffer syndrome in a Chinese adolescent: A case report.

Medicine2026 Mar 06

Lamb-Shaffer syndrome (LAMSHF) is a rare neurodevelopmental disorder caused by pathogenic variants in the SRY-related high-mobility group box 5 (SOX5) gene. Clinical features are heterogeneous, and novel variants continue to be reported, expanding the genotypic and phenotypic spectrum of the disease. A 15-year-old male presented with short stature, mild intellectual disability, epilepsy, and multiple congenital anomalies, including facial dysmorphism and right thumb syndactyly. Whole-exome sequencing identified a novel heterozygous variant in the SOX5 gene, c.1160G>A (p.Ser387Asn), located at 12p12.1. Although initially classified as a variant of uncertain significance according to ACMG criteria, its strong correlation with the clinical phenotype supported the diagnosis of LAMSHF. The patient has been maintained on levetiracetam for epilepsy management and is receiving dental care for maxillofacial deformities. A multidisciplinary rehabilitation approach is recommended. Seizures are well-controlled with no recurrence. The patient demonstrates stable cognitive and functional status under current supportive care. This case reports a novel SOX5 variant associated with LAMSHF and highlights the importance of genetic confirmation in patients with unexplained neurodevelopmental features to guide appropriate management and avoid unnecessary interventions.

#3

Case Report: Identification of a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 in a patient presenting with neurodevelopmental delay and recurrent pulmonary infections.

Frontiers in genetics2026

Heterozygous variants in the ZEB2 gene are known to cause Mowat-Wilson syndrome (MWS). The classical clinical spectrum of MWS includes characteristic facial features, intellectual disability, epilepsy, Hirschsprung disease (HSCR), and various congenital malformations. Reported pathogenic variants have predominantly been truncating variants or missense variants involving the C-terminal zinc-finger domain. To date, no disease-causing missense variant affecting the N-terminal zinc-finger domain has been documented. We report a 3-year-old boy presenting with characteristic facial features, global developmental delay, and recurrent respiratory tract infections. Trio-based exome sequencing identified a de novo heterozygous missense variant in ZEB2, c.652C>T (p. Arg218Trp), located within the N-terminal zinc-finger domain. The patient exhibited a phenotype distinct from classical MWS, characterized by atypical facial dysmorphisms (including an elongated face, midface hypoplasia/depression, frontal bossing, esotropia, and hypertelorism), global developmental delay, and recurrent respiratory infections. Following comprehensive rehabilitation therapy (motor, cognitive, and language training) combined with oral zinc supplementation (elemental zinc 5 mg/day, approximately 0.3 mg/kg), the patient showed a marked reduction in respiratory infections and normalization of immune parameters after 12 months of treatment. This report describes a patient with a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 who presented with neurodevelopmental delay, atypical facial features, and recurrent respiratory infections, alongside a reduction in infection frequency during zinc supplementation. The variant is classified as likely pathogenic, and these observations expand the phenotypic variability potentially associated with ZEB2 variants. Additional cases and functional studies are required to confirm any causal link between the variant, the observed phenotype, and the effects of zinc supplementation.

#4

Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.

Neurobiology of disease2026 Jan

Zinc finger E-box-binding homeobox 2 (ZEB2) is a key transcription factor involved in multiple aspects of nervous system development, including neuronal specification, migration, and differentiation. Loss-of-function variants in ZEB2 cause Mowat-Wilson syndrome (MWS), a severe neurodevelopmental disorder characterized by intellectual disability, epilepsy, and brain structural abnormalities. In this study, we generated and characterized induced pluripotent stem cell (iPSC) lines from MWS patients carrying pathogenic ZEB2 variants. Patient-derived iPSCs retained full pluripotency and were capable of differentiating into all three germ layers, including neural lineages. Upon directed differentiation into neural progenitor cells (NPCs) and early neurons, we identified distinctive transcriptional alterations affecting neuroepithelial-to-radial glia transition and lineage specification. RNA-seq analysis revealed dysregulation of genes involved in cytoskeletal remodeling, extracellular matrix organization, and cell motility. Functional holographic live imaging confirmed a significant increase in motility behavior in MWS NPCs and early neurons, suggesting that altered cell dynamics may underlie aberrant neural circuit formation. Despite these changes, early neuronal markers such as MAP2 were expressed at comparable levels in MWS and control cells. Together, these findings uncover novel cellular and molecular phenotypes associated with ZEB2 deficiency and provide insight into how disrupted progenitor behavior and transcriptional mis-regulation may contribute to the neurodevelopmental features of MWS.

#5

De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons.

medRxiv : the preprint server for health sciences2025 Dec 26

MAP2K4 encodes a kinase that activates the c-Jun N-terminal kinase (JNK) pathway, which is essential for human neurodevelopment. While somatic MAP2K4 loss has been observed in cancer, germline variants have not previously been linked to human disease. We describe ten individuals with de novo or presumed de novo MAP2K4 variants who present with a novel syndromic neurodevelopmental disorder. Shared features include developmental delay or intellectual disability, epilepsy, and variable congenital malformations, most commonly affecting the genitourinary system. To define the mechanism, we generated CRISPR-edited iPSC-derived neurons with MAP2K4 deficiency. These neurons showed reduced JNK pathway activation and abnormal differentiation, characterized by persistence of progenitor-like cells and disrupted neurite morphology. Our findings establish MAP2K4 as a Mendelian neurodevelopmental disorder gene and identify impaired JNK signaling as the underlying mechanism. More broadly, this work expands the spectrum of JNK-pathway disorders and underscores the critical role of JNK signaling in human brain development.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 132

2025

[Clinical features and genetic etiology analysis in a patient with Fliedner-Zweier syndrome caused by a de novo SCAF4 variant].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Lamb-Shaffer syndrome in a Chinese adolescent: A case report.

Medicine
2026

Case Report: Identification of a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 in a patient presenting with neurodevelopmental delay and recurrent pulmonary infections.

Frontiers in genetics
2025

AAV-mediated neuronal expression of FOXG1 restores oligodendrocyte maturation, myelination, and hippocampal structure in mouse models of FOXG1 syndrome.

bioRxiv : the preprint server for biology
2025

De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons.

medRxiv : the preprint server for health sciences
2025

Clinical and Molecular Spectrum of PPP2R1A-Related Neurodevelopmental Disorders: A Systematic Review.

Genes
2025

Syngap1 and the development of murine neocortical progenitor cells.

Nature communications
2025

Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Türkiye: Single Center Experience.

Pediatric diabetes
2026

Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.

Neurobiology of disease
2025

A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.

Molecular biology reports
2025

First Report of a Familiar MYCBP2 Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders.

Balkan journal of medical genetics : BJMG
2026

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies.

Annals of clinical and translational neurology
2025

Identification of CNKSR2 Pathogenic Variant and Detection of Strong XCI in a Female Patient With Severe DEE-SWAS and Phenotype Expansion in Male Patients.

Clinical genetics
2025

Landau-Kleffner Syndrome Can Herald the Diagnosis of GRIN2A Gene Mutation.

Case reports in pediatrics
2025

Identification of a novel microdeletion at 9q21.13 in a family with epilepsy, intellectual disability, and speech disorders and literature review.

Frontiers in genetics
2025

Dynamic electro-clinical features in Guanidinoacetate N-methyltransferase deficiency: A familial case series.

Epilepsia open
2025

Hexasomy of the 15q11q13 region: a detailed report and review of the literature.

European journal of medical genetics
2025

Genotypic and phenotypic characteristics of Turkish patients with phenylalanine metabolism disorders.

Metabolic brain disease
2025

Christianson Syndrome Family Experiences: Results From Caregiver Interviews.

Journal of child neurology
2025

KBG syndrome: report and follow-up on three unrelated patients observed at different ages.

Italian journal of pediatrics
2025

C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis.

bioRxiv : the preprint server for biology
2025

NRXN2 Homozygous Variant Identified in a Family with Global Developmental Delay, Severe Intellectual Disability, EEG Abnormalities and Speech Delay: A new Syndrome?

Clinical EEG and neuroscience
2025

Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.

American journal of human genetics
2025

CHD3-related Snijders Blok-Campeau syndrome with Spastic Paraplegia, Ataxia, and Situs Inversus.

European journal of medical genetics
2025

BRCC3 -Associated Syndromic Moyamoya Angiopathy Diagnosed Through Clinical RNA Sequencing.

Clinical genetics
2024

Identification of a novel TSC1 variant in a family with developmental and epileptic encephalopathies: A case report and literature review.

Medicine
2024

Novel Splice Site Pathogenic Variant in STXBP1 Gene in a Child with Intellectual Disability, Epilepsy, and Autism Spectrum Disorder: A Case Report.

Molecular syndromology
2025

Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice.

Brain : a journal of neurology
2024

Christianson syndrome across the lifespan: genetic mutations and longitudinal study in children, adolescents, and adults.

Journal of medical genetics
2024

Linking Angelman and dup15q data for expanded research (LADDER) database: a model for advancing research, clinical guidance, and therapeutic development for rare conditions.

Therapeutic advances in rare disease
2024

A Missense Variant in HACE1 Is Associated with Intellectual Disability, Epilepsy, Spasticity, and Psychomotor Impairment in a Pakistani Kindred.

Genes
2024

Snyder-Robinson syndrome presenting with learning disability, epilepsy, and osteoporosis: a novel SMS gene variant.

Rare (Amsterdam, Netherlands)
2024

A missense variant in the PACS2 gene cause Epileptic Encephalopathy and seizures in Saudi family.

Pakistan journal of medical sciences
2024

A pathogenic P4HTM gene variant in two brothers with autism spectrum disorder.

Psychiatric genetics
2024

Breaking the rules of SLC6 transporters: Export of the human creatine transporter-1 from the endoplasmic reticulum is supported by its N-terminus.

Journal of neurochemistry
2024

Identification of the DNA methylation signature of Mowat-Wilson syndrome.

European journal of human genetics : EJHG
2024

Genetic outcomes in children with developmental language disorder: a systematic review.

Frontiers in pediatrics
2024

Unfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant.

Scientific reports
2024

Two rare autosomal recessive neurological disorders identified by combined genetic approaches in a single consanguineous family with multiple offspring.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Christianson Syndrome across the Lifespan: An International Longitudinal Study in Children, Adolescents, and Adults.

medRxiv : the preprint server for health sciences
2023

[Phelan-McDermid syndrome associated with a novel heterozygous mutation in the SHANK3 gene].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2023

Mutated Transcripts of ZEB2 Do Not Undergo Nonsense-Mediated Decay in Mowat-Wilson Syndrome.

Molecular syndromology
2023

GDP-Mannose Pyrophosphorylase B (GMPPB)-Related Disorders.

Genes
2022

Genetically unresolved case of Rauch-Steindl syndrome diagnosed by its wolf-hirschhorn associated DNA methylation episignature.

Frontiers in cell and developmental biology
2022

PHF21A Related Disorder: Description of a New Case.

International journal of molecular sciences
2023

Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families.

Clinical genetics
2022

De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Autism: A model of neurodevelopmental diversity informed by genomics.

Frontiers in psychiatry
2022

Differences in Expression of IQSEC2 Transcript Isoforms in Male and Female Cases with Loss of Function Variants and Neurodevelopmental Disorder.

International journal of molecular sciences
2022

Trisomy 20p/monosomy 18p associated with congenital bilateral perisylvian syndrome.

Epileptic disorders : international epilepsy journal with videotape
2022

Obesity and neurodevelopmental and mental health conditions among adolescents aged 10-17 years: The National Survey of Children's Health 2017-2018.

Journal of paediatrics and child health
2022

Three Novel De Novo ZEB2 Variants Identified in Three Unrelated Chinese Patients With Mowat-Wilson Syndrome and A Systematic Review.

Frontiers in genetics
2022

Phenotypic overlap between cardioacrofacial dysplasia-2 and oral-facial-digital syndrome.

European journal of medical genetics
2022

Donor Splice Site Variant in SLC9A6 Causes Christianson Syndrome in a Lithuanian Family: A Case Report.

Medicina (Kaunas, Lithuania)
2021

Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?

Cytogenetic and genome research
2021

Early-onset bradykinetic rigid syndrome and reflex seizures in a child with PURA syndrome.

Epileptic disorders : international epilepsy journal with videotape
2021

Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review.

Children (Basel, Switzerland)
2021

A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis.

European journal of human genetics : EJHG
2021

Genetic Testing Contributes to Diagnosis in Cerebral Palsy: Aicardi-Goutières Syndrome as an Example.

Frontiers in neurology
2021

Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder.

Neurology. Genetics
2021

EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum.

Orphanet journal of rare diseases
2021

Polygenic burden has broader impact on health, cognition, and socioeconomic outcomes than most rare and high-risk copy number variants.

Molecular psychiatry
2021

Ocular manifestations and surgical interventions in pediatric patients with Koolen-de-Vries syndrome.

Ophthalmic genetics
2021

UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism.

American journal of human genetics
2020

The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Frontiers in synaptic neuroscience
2020

Zeb2 regulates the balance between retinal interneurons and Müller glia by inhibition of BMP-Smad signaling.

Developmental biology
2020

Molecular, physiological and behavioral characterization of the heterozygous Df[h15q13]/+ mouse model associated with the human 15q13.3 microdeletion syndrome.

Brain research
2021

ODLURO syndrome: personal experience and review of the literature.

La Radiologia medica
2020

Reduced anogenital distance, hematuria and left renal hypoplasia in a patient with 13q33.1-34 deletion: case report and literature review.

BMC pediatrics
2020

Loss of SLC9A6/NHE6 impairs nociception in a mouse model of Christianson syndrome.

Pain
2020

Mowat-Wilson syndrome: growth charts.

Orphanet journal of rare diseases
2020

Lamotrigine induced Brugada-pattern in a patient with genetic epilepsy associated with a novel variant in SCN9A.

Gene
2020

Expanding the phenotypic spectrum consequent upon de novo WDR37 missense variants.

Clinical genetics
2020

Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy.

Epilepsy research
2020

Classification of the Molecular Defects Associated with Pathogenic Variants of the SLC6A8 Creatine Transporter.

Biochemistry
2020

Angelman Syndrome: From Mouse Models to Therapy.

Neuroscience
2020

Age-dependent epileptic encephalopathy associated with an unusual co-occurrence of ZEB2 and SCN1A variants.

Epileptic disorders : international epilepsy journal with videotape
2020

Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction.

Clinical genetics
2020

Chromosome 15q BP3 to BP5 deletion is a likely locus for speech delay and language impairment: Report on a four-member family and an unrelated boy.

Molecular genetics &amp; genomic medicine
2020

Genetic interaction screen for severe neurodevelopmental disorders reveals a functional link between Ube3a and Mef2 in Drosophila melanogaster.

Scientific reports
2020

Commentary on "Bosch-Boonstra-Schaaf Optic Atrophy Syndrome Presenting as New-Onset Psychosis in a 32-Year-Old Man: A Case Report and Literature Review".

Journal of psychiatric practice
2020

Bosch-Boonstra-Schaaf Optic Atrophy Syndrome Presenting as New-Onset Psychosis in a 32-Year-Old Man: A Case Report and Literature Review.

Journal of psychiatric practice
2020

Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability.

The Journal of clinical investigation
2019

A new novel nonsense mutation in AIPL1 in a LCA4 family.

Ophthalmic genetics
2020

A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.

European journal of medical genetics
2019

Postnatal clinical phenotype of five patients with Pallister-Killian Syndrome (tetrasomy 12p): Interest of array CGH for diagnosis and review of the literature.

Molecular genetics &amp; genomic medicine
2019

A de novo variant in RAC3 causes severe global developmental delay and a middle interhemispheric variant of holoprosencephaly.

Journal of human genetics
2019

Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.

American journal of medical genetics. Part A
2019

Comprehensive Analysis of Rare Variants of 101 Autism-Linked Genes in a Hungarian Cohort of Autism Spectrum Disorder Patients.

Frontiers in genetics
2019

Phenotypic features of a microdeletion in chromosome band 20p13: A case report and review of the literature.

Molecular genetics &amp; genomic medicine
2018

Rare Case of a Heterozygous Microdeletion 9q21.11-q21.2: Clinical and Genetic Characteristics.

Balkan journal of medical genetics : BJMG
2019

Association of Child Neurology-Indian Epilepsy Society Consensus Document on Social and Legal Aspects of Childhood Epilepsy (SOLACE).

Indian journal of pediatrics
2019

LETM1 is required for mitochondrial homeostasis and cellular viability (Review).

Molecular medicine reports
2020

Novel insights into the clinical and molecular spectrum of congenital disorders of autophagy.

Journal of inherited metabolic disease
2019

Deep phenotyping of 14 new patients with IQSEC2 variants, including monozygotic twins of discordant phenotype.

Clinical genetics
2018

Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.

PLoS genetics
2018

PI4K2A deficiency in an intellectual disability, epilepsy, myoclonus, akathisia syndrome.

Annals of clinical and translational neurology
2018

West syndrome, developmental and epileptic encephalopathy, and severe CNS disorder associated with WWOX mutations.

Epileptic disorders : international epilepsy journal with videotape
2018

Loss of Protocadherin-12 Leads to Diencephalic-Mesencephalic Junction Dysplasia Syndrome.

Annals of neurology
2019

Requirement of the Mowat-Wilson Syndrome Gene Zeb2 in the Differentiation and Maintenance of Non-photoreceptor Cell Types During Retinal Development.

Molecular neurobiology
2018

Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome.

American journal of human genetics
2018

De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.

Human genetics
2017

Syndrome of X linked intellectual disability, epilepsy, progressive brain atrophy and large head associated with SLC9A6 mutation.

BMJ case reports
2018

Neuroimaging findings in Pallister-Killian syndrome.

The neuroradiology journal
2018

A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function.

Human mutation
2018

Congenital Disorders of Autophagy: What a Pediatric Neurologist Should Know.

Neuropediatrics
2017

Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.

Human molecular genetics
2017

A novel mutation in GMPPA in siblings with apparent intellectual disability, epilepsy, dysmorphism, and autonomic dysfunction.

American journal of medical genetics. Part A
2017

PIGO deficiency: palmoplantar keratoderma and novel mutations.

Orphanet journal of rare diseases
2017

[MECP2 duplication syndrome: a clinical analysis of three cases and literature review].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2017

Alterations in the carnitine cycle in a mouse model of Rett syndrome.

Scientific reports
2017

EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMO.

Human mutation
2017

Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes.

Scientific reports
2016

A novel mutation in PGAP2 gene causes developmental delay, intellectual disability, epilepsy and microcephaly in consanguineous Saudi family.

Journal of the neurological sciences
2016

Molecular cytogenetic characterization of an inv dup(15) chromosome presenting as a small supernumerary marker chromosome associated with the inv dup(15) syndrome.

Taiwanese journal of obstetrics &amp; gynecology
2016

Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.

Pediatric neurology
2016

SPATA5 mutations cause a distinct autosomal recessive phenotype of intellectual disability, hypotonia and hearing loss.

Orphanet journal of rare diseases
2016

15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes.

Translational psychiatry
2016

Sip1 regulates the generation of the inner nuclear layer retinal cell lineages in mammals.

Development (Cambridge, England)
2016

Epilepsy and cataplexy in Angelman syndrome. Genotype-phenotype correlations.

Research in developmental disabilities
2016

MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.

European journal of medical genetics
2016

Angelman Syndrome: A Case Report.

Iranian journal of child neurology
2016

A 16q12.2q21 deletion identified in a patient with developmental delay, epilepsy, short stature, and distinctive features.

Congenital anomalies
2016

Phenotypic variability in patients with interstitial 6q21-q22 microdeletion and Acro-Cardio-Facial syndrome.

American journal of medical genetics. Part A
2016

Focal cortical dysplasia, microcephaly and epilepsy in a boy with 1q21.1-q21.3 duplication.

European journal of medical genetics
2016

TWO CASES WITH DIFFERENT EPILEPSY TYPE AND DYSMORPHIC FEATURES ASSOCIATED WITH 17q21.31 MICRODELETION SYNDROME.

Genetic counseling (Geneva, Switzerland)
2016

Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

Brain : a journal of neurology
2016

X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities.

Disease models &amp; mechanisms
2016

Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome.

Clinical genetics
2015

Dysregulation of FOXG1 by ring chromosome 14.

Molecular cytogenetics
2015

[Inherited GPI deficiencies:a new disease with intellectual disability and epilepsy].

No to hattatsu = Brain and development
2015

Homozygous missense mutation in STYXL1 associated with moderate intellectual disability, epilepsy and behavioural complexities.

European journal of medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies.
    Annals of clinical and translational neurology· 2026· PMID 41074240mais citado
  2. Lamb-Shaffer syndrome in a Chinese adolescent: A case report.
    Medicine· 2026· PMID 41790631mais citado
  3. Case Report: Identification of a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 in a patient presenting with neurodevelopmental delay and recurrent pulmonary infections.
    Frontiers in genetics· 2026· PMID 41788411mais citado
  4. Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.
    Neurobiology of disease· 2026· PMID 41325909mais citado
  5. De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons.
    medRxiv : the preprint server for health sciences· 2025· PMID 41480045mais citado
  6. Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China.
    Orphanet J Rare Dis· 2024· PMID 38178189recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2798(Orphanet)
  2. OMIM OMIM:600176(OMIM)
  3. MONDO:0010840(MONDO)
  4. Epilepsia(PCDT · Ministério da Saúde)
  5. GARD:409(GARD (NIH))
  6. Busca completa no PubMed(PubMed)
  7. Q55782834(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia
Compêndio · Raras BR

Síndrome de paquigiria-perturbação do desenvolvimento intelectual-epilepsia

ORPHA:2798 · MONDO:0010840
🇧🇷 Brasil SUS
Geral
Prevalência
<1 / 1 000 000
Casos
5 casos conhecidos
CID-10
G40.4 · Outras epilepsias e síndromes epilépticas generalizadas
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1838491
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades